Vasoactive Drugs and Splanchnic Perfusion

  • J. Takala


Vasoactive drugs, especially sympathomimetic amines, are often needed to support tissue perfusion in circulatory failure. The effects of sympathomimetic drugs on splanchnic circulation and metabohsm have not been well documented in humans. Based on the available data, it seems evident that the regional hemodynamic effects of various vasoactive drugs in intensive care patients can neither be predicted from their pharmacological characteristics alone nor extrapolated from experimental models. Inadequate splanchnic tissue perfusion may contribute to the development of multiple organ failure and ultimately death in critically ill patients. The catecholamines used to support the circulatory functions may markedly modify the activity of various metabolic pathways in the liver and simultaneously alter the splanchnic blood flow and its distribution. Accordingly, catecholamines may induce regional perfusion abnormalities and alter the balance between regional oxygen delivery and tissue metabolic demands. Due to these interactions, the effects of vasoactive drugs on splanchnic oxygen transport and substrate metabohsm should be evaluated in intensive care patients.


Regional Blood Flow Intensive Care Patient Vasoactive Drug Splanchnic Blood Flow Organ Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ruffolo RR Jr, Fondacaro JD, Levitt B, Edwards RM, Kinter LB (1987) Pharmacologic manipulation of regional blood flow. In: Snyder JV, Pinsky MR (eds) Oxygen transport in critically ill, 1st edn, Year Book Medical, Chicago, pp 450–474Google Scholar
  2. 2.
    Vernon DD, Garret JS, Banner W Jr, Dean JM (1992) Hemodynamic effects of dobutamine in an intact animal model. Crit Care Med 20:1322–1329PubMedCrossRefGoogle Scholar
  3. 3.
    Lokhandwala MF, Jandhyala BS (1992) Effects of dopaminergic agonists on organ blood flow and function. Clin Intensive Care [Suppl] 3:12–15Google Scholar
  4. 4.
    Breslow MJ, Miller CF, Parker SD, Walman AT, Traystman RJ (1987) Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol H291-H300Google Scholar
  5. 5.
    Webb AR, Moss RF, Tighe D, Al-Saady N, Bennet ED (1991) The effects of dobutamine, dopexamine and fluid on hepatic histological responses to porcine faecal peritonitis. Intensive Care Med 17:487–493PubMedCrossRefGoogle Scholar
  6. 6.
    Ruokonen E, Takala J, Kari A, Saxén H, Mertsola J, Hansen EJ (1993) Regional blood flow and oxygen transport in septic shock. Crit Care Med 21:1296–1303PubMedCrossRefGoogle Scholar
  7. 7.
    Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354–1357PubMedCrossRefGoogle Scholar
  8. 8.
    Fiddian-Green RG, Baker S (1987) Predictive value of the stomach wall pH for complications after cardiac operations: comparison with other monitoring. Crit Care Med 15:153–156PubMedCrossRefGoogle Scholar
  9. 9.
    Chiara O, Giomarelli PP, Biagioli B, Rosi R, Gattinoni L (1987) Hypermetabolic response after hypothermic cardiopulmonary bypass. Crit Care Med 15:995–1000PubMedCrossRefGoogle Scholar
  10. 10.
    Ruokonen E, Takala J, Kari A (1993) Regional blood flow and oxygen transport in low cardiac output syndrome after cardiac surgery. Crit Care Med 21:1304–1311PubMedCrossRefGoogle Scholar
  11. 11.
    Kuttila K, Niinikoski J, Haglund U (1990) Visceral and peripheral tissue perfusion after cardiac surgery. Scand J Thor Cardiovasc Surg 25:57–62CrossRefGoogle Scholar
  12. 12.
    Leier CV, Heban BT, Huss P, Bush CA, Lewis RP (1978) Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58:466–475PubMedGoogle Scholar
  13. 13.
    Leier CV, Binkley PF, Carpenter J, Randolph PH, Unverferth DV (1988) Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 62:94–99PubMedCrossRefGoogle Scholar
  14. 14.
    Parviainen I, Ruokonen E, Takala J (1995) Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intramucosal pH after cardiac surgery. Br J Anaesth 74:277–282PubMedCrossRefGoogle Scholar
  15. 15.
    Uusaro A, Ruokonen E, Takala J (1995) Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 74:149–154PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • J. Takala

There are no affiliations available

Personalised recommendations